Agenus Inc / Stock Price
13.62 +1.27 (10.28%)
After hours: 13.88 +0.26 (1.88%)
AGEN(NASDAQ)
May 24, 4:00 PM EDT · Currency in USD · Disclaimer
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
People also ask
Is Agen a good stock to buy?
What is the prediction for Agen stock in 2025?
What is the Nasdaq forecast for Agen?
Who owns Agen stock?
AGEN | Complete Agenus Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients.
People also search for
Discover real-time Agenus Inc. Common Stock (AGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
AGEN Agenus Inc. 12,441. $13.62. $1.27. (10.28%). Today. Watchers, 12,441. 52-Wk Low, $4.78. 52-Wk High, $42.60. Market Cap, $286.01M. Volume, 695,430.00 ...
The commune of Agen is the prefecture of the Lot-et-Garonne department in Nouvelle-Aquitaine, southwestern France. It lies on the river Garonne 135 ...
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its ...
Get Agenus Inc (AGEN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases.